Tag: GEP

SkylineDx’s Merlin Melanoma Assay shows its ability to reduce SLNB by over 40% in a Danish Multicenter Validation Study

In the independent blinded validation study, Merlin accurately identifies melanoma patients at low risk of metastatic disease, including sentinel lymph node metastasis The potential SLNB surgery...

SkylineDx’s Merlin Melanoma Assay shows its ability to reduce SLNB by over 40% in a Danish Multicenter Validation Study

In the independent blinded validation study, Merlin accurately identifies melanoma patients at low risk of metastatic disease, including sentinel lymph node metastasis The potential SLNB surgery...

TARIFF PAUSE SPURS GLOBAL MANUFACTURING ACTIVITY IN JUNE, WITH GLOBAL SUPPLY CHAINS NOW OPERATING CLOSE TO FULL CAPACITY: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX

Europe exits two-year slump, led by German export rebound and domestic demand recoveryU.S. manufacturers purchasing surges ahead of U.S. 'tariff pause' endingAsia supply chains...

TARIFF PAUSE SPURS GLOBAL MANUFACTURING ACTIVITY IN JUNE, WITH GLOBAL SUPPLY CHAINS NOW OPERATING CLOSE TO FULL CAPACITY: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX

Europe exits two-year slump, led by German export rebound and domestic demand recoveryU.S. manufacturers purchasing surges ahead of U.S. 'tariff pause' endingAsia supply chains...

TARIFF PAUSE SPURS GLOBAL MANUFACTURING ACTIVITY IN JUNE, WITH GLOBAL SUPPLY CHAINS NOW OPERATING CLOSE TO FULL CAPACITY: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX

Europe exits two-year slump, led by German export rebound and domestic demand recoveryU.S. manufacturers purchasing surges ahead of U.S. 'tariff pause' endingAsia supply chains...

Camurus’ POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients

CAM2029 reduces liver and cyst volume growth compared to placebo Well tolerated with no new or unexpected safety findingsA follow-up Phase 3 study will be...

ASIAN MANUFACTURING ACTIVITY FALLS TO 17-MONTH LOW AS TARIFFS HIT CHINA-BASED SUPPLIERS: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX

U.S. manufacturers front-load inventories in anticipation of further tariffsNorth American factories remain underutilized, with persistent weakness in Mexico and Canada Europe inches toward industrial...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsGEP

Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide

Zealand Pharma announces Boehringer Ingelheim’s survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while...

Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide

Tag: GEP

SkylineDx’s Merlin Melanoma Assay shows its ability to reduce SLNB by over 40% in a Danish Multicenter Validation Study

SkylineDx’s Merlin Melanoma Assay shows its ability to reduce SLNB by over 40% in a Danish Multicenter Validation Study

TARIFF PAUSE SPURS GLOBAL MANUFACTURING ACTIVITY IN JUNE, WITH GLOBAL SUPPLY CHAINS NOW OPERATING CLOSE TO FULL CAPACITY: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX

TARIFF PAUSE SPURS GLOBAL MANUFACTURING ACTIVITY IN JUNE, WITH GLOBAL SUPPLY CHAINS NOW OPERATING CLOSE TO FULL CAPACITY: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX

TARIFF PAUSE SPURS GLOBAL MANUFACTURING ACTIVITY IN JUNE, WITH GLOBAL SUPPLY CHAINS NOW OPERATING CLOSE TO FULL CAPACITY: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX

Camurus’ POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients

ASIAN MANUFACTURING ACTIVITY FALLS TO 17-MONTH LOW AS TARIFFS HIT CHINA-BASED SUPPLIERS: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us